MedPath

The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty

Not Applicable
Completed
Conditions
Transfusion
Hip Arthroplasty
Registration Number
NCT04304287
Lead Sponsor
Clinical Hospital Centre Zagreb
Brief Summary

The investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized.

Detailed Description

Total hip arthroplasty is procedure followed with large perioperative and postoperative blood loss. In order to avoid the application of large amounts of allogeneic blood, preoperative autologous blood donation as a tipe of autologous transfusion have been developed.

In this study, the investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized.

Participants were divided into three groups: the first group donated one dose of autologous blood 14 days preoperatively, the second group donated one dose of autologous blood 72 hours preoperatively and a third group was not donated autologous blood.

The blood parameters, hemodynamic stability, bleeding, the need for application of autologous or homologous blood and length of hospital stay were compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • subject older than 18 years
  • subject has primary coxarthrosis
  • subject has indication for total hip replacement
Exclusion Criteria
  • subject has secondary coxarthrosis
  • subject has need for revision endoprosthesis
  • history of autoimmune, malignancy or coagulation disorder
  • history of myocardial infarct or cerebrovascular insult in last 6 months
  • history of angina pectoris and unregulated hypertension
  • history of renal or liver failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient red blood cells value6 days

analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day

Patient hematocrit value6 days

analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day

Need for autologous blood transfusion6 days

Based on blood count and hemodynamic stability

Need for homologous blood transfusion6 days

Based on blood count and hemodynamic stability

Patient hemoglobin value6 days

analysis of blood sample day before surgery, 3 hours after surgery, on first, second, fifth postoperative day and on sixth postoperative day

Secondary Outcome Measures
NameTimeMethod
Length of hospital stay6 days

measure of length of hospital stay

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.